Results 231 to 240 of about 35,670 (265)
Some of the next articles are maybe not open access.

Interferon‐gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases, 2013
AbstractObjectiveThe aim of this study was to analyze the results of interferon‐gamma release assays (IGRAs) and tuberculin skin tests (TST) performed to detect latent tuberculosis infection (LTBI) in patients with rheumatoid arthritis (RA).MethodsInterferon‐γ release assays and TST test results were summarized and systematically reviewed.ResultsFour ...
Gwan Gyu, Song   +2 more
openaire   +2 more sources

In vitro interferon-gamma release test in patients with drug-induced pemphigus.

The Israel Medical Association journal : IMAJ, 2008
Drug-specific CD8+ TH1 lymphocytes have been found in the peripheral blood and involved skin of patients with drug-induced bullous exanthems.To determine whether the interferon-gamma release test can identify culprit drugs in pemphigus patients.Clinical and laboratory workup for pemphigus was performed in 14 pemphigus vulgaris patients who had been ...
Ilan, Goldberg   +2 more
openaire   +1 more source

An interferon-gamma release assay test performs well in routine screening for tuberculosis.

Danish medical journal, 2015
A positive interferon-gamma release assay (IGRA) is regarded as proof of latent Mycobacterium tuberculosis infection. We conducted an evaluation of the IGRA test "T-SPOT.TB" to test its performance during clinical routine use by analysing the positivity rate and odds, effect of season and sensitivity.Data from T-SPOT.TB testing together with age and ...
Allan Vestergaard, Danielsen   +4 more
openaire   +1 more source

An interferon-gamma release assay test performs well in routine screening for tuberculosis

2014
Introduction: A positive interferon-gamma release assay (IGRA) is regarded as proof of latent Mycobacterium tuberculosis infection. We conducted an evaluation of the IGRA test “T-SPOT.TB” to test its performance during clinical routine use by analysing the positivity rate and odds, effect of season and sensitivity.
Vestergaard Danielsen, Allan   +4 more
openaire   +1 more source

Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination

Rheumatology International, 2022
Kalina Tumangelova-Yuzeir   +2 more
exaly  

[Interferon gamma release assay (IGRA) tests].

Revue des maladies respiratoires, 2019
P, Le Palud, J-L, Herrmann, E, Bergot
openaire   +1 more source

Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

Journal of Pediatrics, 2021
Olaf Neth   +2 more
exaly  

Home - About - Disclaimer - Privacy